|
1
|
Aydinli M and Bayraktar Y: Budd-Chiari
syndrome: Etiology, pathogenesis and diagnosis. World J
Gastroenterol. 13:2693–2696. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Valla DC: The diagnosis and management of
the Budd-Chiari syndrome: Consensus and controversies. Hepatology.
38:793–803. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Slakey DP, Klein AS, Venbrux AC and
Cameron JL: Budd-Chiari syndrome: Current management options. Ann
Surg. 233:522–527. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rautou PE, Plessier A, Condat B and Valla
D: Primary Budd-Chiari syndrome. Sang Thrombose Vaisseaux.
22:201–208. 2010.
|
|
5
|
Pati S, Bhattacharya S and Rakshit VM:
Pregnancy complicated by Budd-Chiari syndrome and antiphospholipid
syndrome. J Obstet Gynaecol. 29:145–146. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Valla D, Casadevall N, Lacombe C, Varet B,
Goldwasser E, Franco D, Maillard JN, Pariente EA, Leporrier M and
Rueff B: Primary myeloproliferative disorder and hepatic vein
thrombosis. A prospective study of erythroid colony formation in
vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med.
103:329–334. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Denninger MH, Chait Y, Casadevall N,
Hillaire S, Guillin MC, Bezeaud A, Erlinger S, Briere J and Valla
D: Cause of portal or hepatic venous thrombosis in adults: The role
of multiple concurrent factors. Hepatology. 31:587–591. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Usui T, Kitano K, Midorikawa T, Yoshizawa
K, Kobayashi H, Tanaka E, Matsunami H, Kawasaki S and Kiyosawa K:
Budd-Chiari syndrome caused by hepatic vein thrombosis in a patient
with myeloproliferative disorder. Intern Med. 35:871–875. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Patel RK, Lea NC, Heneghan MA, Westwood
NB, Milojkovic D, Thanigaikumar M, Yallop D, Arya R, Pagliuca A,
Gaken J, et al: Prevalence of the activating JAK2, tyrosine kinase
mutation V617F in the Budd-Chiari syndrome. Gastroenterology.
130:2031–2038. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pieri G, Theocharidou E and Burroughs AK:
Liver in haematological disorders. Best Prac Res Clin
Gastroenterol. 27:513–530. 2013. View Article : Google Scholar
|
|
11
|
Espinosa G, Font J, Garcia-Pagan JC,
Tassies D, Reverter JC, Gaig C, Cervantes F, Cervera R, Bosch J and
Ingelmo M: Budd-Chiari syndrome secondary to antiphospholipid
syndrome: Clinical and immunologic characteristics of 43 patients.
Medicine (Baltimore). 80:345–354. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qi X, Yang Z, Bai M, Shi X, Han G and Fan
D: Meta-analysis: The significance of screening for JAK2V617F
mutation in Budd-Chiari syndrome and portal venous system
thrombosis. Aliment Pharmacol Ther. 33:1087–1103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Janssen HL, Meinardi JR, Vleggaar FP, van
Uum SH, Haagsma EB, van Der Meer FJ, van Hattum J, Chamuleau RA,
Adang RP, Vandenbroucke JP, et al: Factor V Leiden mutation,
prothrombin gene mutation, and deficiences in coagulation
inhibitors associated with Budd-Chiari syndrome and portal vein
thrombosis: Results of a case-control study. Blood. 96:2364–2368.
2000.PubMed/NCBI
|
|
14
|
Plessier A, Sibert A, Hakime A, Consigny
Y, Zappa M, Denninger MH, Condat B, Farges O, Chagneau C, de
Ledinghen V, et al: Aiming at minimal invasiveness as a therapeutic
strategy for Budd-Chiari syndrome. Hepatology. 44:1308–1316. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang L, Feng Z, Wang X, Wang X and Zhang
X: DEGseq: An R package for identifying differentially expressed
genes from RNA-seq data. Bioinformatics. 26:136–138. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nagalakshmi U, Waern K and Snyder M:
RNA-Seq: A method for comprehensive transcriptome analysis. Curr
Protoc Mol Biol Chapter. 4:4.11.1–14.11.13. 2010.
|
|
17
|
Zhao S, Fung-Leung WP, Bittner A, Ngo K
and Liu X: Comparison of RNA-Seq and microarray in transcriptome
profiling of activated T cells. PloS One. 9:e786442014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chiodoni C, Colombo MP and Sangaletti S:
Matricellular proteins: From homeostasis to inflammation, cancer,
and metastasis. Cancer Metastasis Rev. 29:295–307. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tripodo C, Sangaletti S, Guarnotta C,
Piccaluga PP, Cacciatore M, Giuliano M, Franco G, Chiodoni C,
Sciandra M, Miotti S, et al: Stromal SPARC contributes to the
detrimental fibrotic changes associated with myeloproliferation
whereas its deficiency favors myeloid cell expansion. Blood.
120:3541–3554. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livun A, Manshouri T, Kušec R, Zhang Y,
Kantarjian HM and Verstovšek S: Expression of a set of cell-stroma
interacting genes in patients with primary myelofibrosis.
Proceedings of the 14th Congress of European Hematology
Association, Berlin. 2009;
|
|
21
|
Lu M, Xia L, Liu YC, Hochman T, Bizzari L,
Aruch D, Lew J, Weinberg R, Goldberg JD and Hoffman R: Lipocalin
produced by myelofibrosis cells affects the fate of both
hematopoietic and marrow micro environmental cells. Blood.
126:972–982. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Skov V, Larsen TS, Thomassen M, Riley CH,
Jensen MK, Bjerrum OW, Kruse TA and Hasselbalch HC: Molecular
profiling of peripheral blood cells from patients with polycythemia
vera and related neoplasms: Identification of deregulated genes of
significance for inflammation and immune surveillance. Leuk Res.
36:1387–1392. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vassen L, Okayama T and Moroy T: Gfi1b:
Green fluorescent protein knock-in mice reveal a dynamic expression
pattern of Gfi1b during hematopoiesis that is largely complementary
to Gfi1. Blood. 109:2356–2364. 2007. View Article : Google Scholar : PubMed/NCBI
|
